LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
1. Identify patient who need genetic testing for VEXAS
2. Describe the pathophysiology of VEXAS
3. Describe treatment options for patients with VEXAS
Session date:
01/24/2023 - 8:30am to 9:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Miriam Friedman, M.D.